Citurgia Biochemicals MD, chairman, board of directors and AGM
BSE: 506373Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 19 Oct 2026. Previous close ₹103.45.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,353 Cr1,246th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 1
Citurgia Biochemicals board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.
- ChairpersonREENA DEVI MANDAL
6 directors3 independent1 executive2 non-executive
- DHARMENDRANon-executive · joined Jan 2021 · 1 listed board · 1 committee seat
- VIVEK SINGHIndependent · joined Nov 2023 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- REENA DEVI MANDAL · ChairpersonIndependent · joined Mar 2023 · 60 months as independent · 2 listed boards · 1 as independent · 2 committee seats
- KASHI NATHExecutive · joined Mar 2022 · 1 listed board · 1 as independent · 1 committee seat
- SUBHASH SAHUNon-executive · joined Aug 2022 · 1 listed board · 1 as independent · 1 committee seat
- JITENDRAIndependent · joined Aug 2022 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 31 Aug 20266 of 6 present3 independent · 18 days in between
- 12 Aug 20266 of 6 present3 independent · 18 days in between
- 24 Jul 20266 of 6 present3 independent · 54 days in between
- 30 May 20266 of 6 present3 independent · no day in between
1 earlier meeting
- 29 May 20266 of 6 present3 independent
Audit Committee
Chair VIVEK SINGH
KASHI NATH, REENA DEVI MANDAL
- 12 Aug 20263 of 3 present2 independent · 73 days in between
- 30 May 20263 of 3 present2 independent · no day in between
- 29 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair VIVEK SINGH
REENA DEVI MANDAL, DHARMENDRA
- 12 Aug 20263 of 3 present2 independent · 73 days in between
- 30 May 20263 of 3 present2 independent · no day in between
- 29 May 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair VIVEK SINGH
REENA DEVI MANDAL, DHARMENDRA
- 12 Aug 20263 of 3 present2 independent · 73 days in between
- 30 May 20263 of 3 present2 independent · no day in between
- 29 May 20263 of 3 present2 independent
Risk Management Committee
Chair VIVEK SINGH
REENA DEVI MANDAL, DHARMENDRA
- 12 Aug 20263 of 3 present2 independent · 73 days in between
- 30 May 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- G.P.KESHRI & ASSOCIATESNo peer-review certificate stated
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.